12:00 AM
 | 
Jul 22, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Kyowa Hakko Kirin, Otsuka Pharmaceutical sales and marketing update

Kyowa launched once-daily, oral Onglyza saxagliptin in Japan to treat Type II diabetes. The product has a Japanese National Health Insurance (NHI) list price of ¥110.20 ($1.11) per 2.5 mg tablet and ¥166...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >